FDA Adverse Event Injury Summary report: N

ASP6025

MDR report key: 23232042 · Received October 7, 2025

Report

Report Number
8010478-2025-00029
Event Type
Injury
Date Received
October 7, 2025
Date of Event
September 8, 2025
Report Date
December 2, 2025
Manufacturer
LEICA BIOSYSTEMS NUSSLOCH GMBH
Product Code
IEO
Adverse Event
Yes
Report Source
Manufacturer report
Reporter Location
JA
Reporter Occupation
OTHER
Health Professional
N

Narratives

Additional Manufacturer Narrative · 0

THE INVESTIGATING ENGINEER, QUALITY ASSURANCE & REGULATORY AFFAIRS HAS DETERMINED THE FOLLOWING: ACCORDING TO THE DEVICE LOGS STEP AN EXTERNAL POWER OUTAGE OCCURRED AT 13:51 DURING THE 9TH PROCESSING STEP. THE POWER OUTAGE LASTED FOR 15 MINUTES. AN ANALYSIS OF THE DEVICE LOGS SHOWED THAT THE POWER OUTAGE DID NOT AFFECT ANY PROCESSES THAT COULD HAVE CAUSED THE WHITE APPEARANCE OF THE SAMPLES DESCRIBED BY THE CUSTOMER. THE INSTRUMENT DETERMINED THAT THE ENVIRONMENT OF STEP 9 WAS EQUIVALENT TO THE SAFE REAGENT ENVIRONMENT, SO IT MAINTAINED THE CURRENT STATE. THE CUSTOMER DETECTED THE POWER OUTAGE OF THE INSTRUMENT, ADJUSTED THE DURATION OF THE 9TH STEP (FROM 6 HOURS TO 5 HOURS) AND SUBSEQUENT STEPS AT 14:10, AND THEN RESTARTED THE PROTOCOL FROM THE 9TH STEP. ACCORDING TO THE CUSTOMER, AT THE START OF THE RUN, THEY MANUALLY REFILLED A XYLENE REAGENT BOTTLE THAT WAS LOW, AND THERE IS A POSSIBILITY THAT THE WRONG REAGENT MAY HAVE BEEN ADDED AT THAT TIME. GIVEN BOTH THE LOG FILE ANALYSIS, AS WELL AS THE STATEMENT FROM THE CUSTOMER, THE FINAL ROOT CAUSE FOR THIS CASE HAS BEEN CONCLUDED TO BE AN APPLICATION ISSUE WITH AN INCORRECTLY CHANGED REAGENT. LEICA BIOSYSTEMS HAS BEEN INFORMED THAT AFTER CLEANING AND RE-FILLING OF THE XYLENE REAGENT BOTTLE WITH FRESH XYLENE THE PROCESSING QUALITY HAS RETURNED TO NORMAL. THE DEVICE IS PERFORMING AS EXPECTED.

Description of Event or Problem · 0

ON SEPTEMBER 8TH, 2025 LEICA BIOSYSTEMS RECEIVED A COMPLAINT THAT, FOLLOWING A SCHEDULED POWER OUTAGE AT THE CUSTOMER SITE ON (B)(6) 2025, THE SAMPLE PROCESSING OF THE IMPACTED RUN WAS NEGATIVELY IMPACTED. ON (B)(6) 2025, LEICA BIOSYSTEMS NUSSLOCH GMBH WAS INFORMED THAT ONE TISSUE SAMPLE OF THE IMPACTED RUN COULD NOT BE DIAGNOSED. ON (B)(6) 2025, LEICA BIOSYSTEMS NUSSLOCH GMBH WAS INFORMED THAT ONE PATIENT HAD TO BE RE-BIOPSIED.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
2614527 ASP6025 PROCESSOR, TISSUE, AUTOMATED IEO LEICA BIOSYSTEMS NUSSLOCH GMBH ASP6025 120V/50-60 HZ

Patients

Seq Age Sex Outcome Treatment
1 NA Unknown